Skip to content
ppharmaranks
Menu

IBTROZI vs KISQALI

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 23, 2026·How we rate

Possible drug interaction. IBTROZI and KISQALI are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Rating

New
70/100

Pharmacy pays

Type

RX
RX

Active ingredient

TALETRECTINIB ADIPATE
RIBOCICLIB SUCCINATE

Manufacturer

Dosage forms

Capsule
Tablet

Drug class

Kinase Inhibitor
Kinase Inhibitor

Boxed warning

None
None

Treats

Non-Small-Cell Lung Carcinoma
Breast Neoplasms

Frequently asked questions

What is the difference between Ibtrozi and Kisqali?

Ibtrozi contains Taletrectinib Adipate, while Kisqali contains Ribociclib Succinate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.